CSIMarket
 
Inmode Ltd   (NASDAQ: INMD)
 

Inmode Ltd's Customers Performance

INMD



 
INMD's Source of Revenues During the corresponding time, Inmode Ltd saw a revenue deteriorated by -6.16 % year on year, While revenue at the Inmode Ltd 's corporate clients

List of INMD Customers




for the same period Inmode Ltd revnue deteriorated by -6.16 % year on year,

List of INMD Customers

Inmode Ltd's Business Units
CODM    100 % of total Revenue
Israel    0.92 % of total Revenue
UNITED STATES    53.62 % of total Revenue
Europe    21.33 % of total Revenue
Asia    13.28 % of total Revenue
Other Country    10.85 % of total Revenue
Capital Equipment Revenues    78.04 % of total Revenue
Consumables And Service Revenues    21.96 % of total Revenue






Inmode Ltd's Comment on Sales, Marketing and Customers



The company provides aesthetic and wellness office-based procedures, focusing on medical specialties such as ear, nose, and throat (ENT) specialists and urologists. For ENT specialists, it is developing a platform and handpieces for treating snoring and rhinitis, including a handpiece for turbinate treatment utilizing Deep Subdermal Fractional RF technology. For urologists, the company markets ApexRF, a device that uses RF energy to provide temporary relief of muscle spasms and improve local blood circulation. The company supports its products with clinical evidence, having completed 105 third-party clinical studies and conducting 11 ongoing studies, along with over 110 peer-reviewed publications. It offers post-sales training and support services to physicians, including safety and instructional videos and personalized marketing assistance, to enhance procedural offerings and customer adoption.


  News about Inmode Ltd Contracts

InMode Ltd. Faces Shareholder Class Action Lawsuit: Assessing the Impact on the Company

InMode Ltd. (NASDAQ: INMD), a prominent medical technology company, finds itself in the midst of a class action lawsuit filed by investors. P...




Inmode Ltd’s Comment on Sales, Marketing and Customers


The company provides aesthetic and wellness office-based procedures, focusing on medical specialties such as ear, nose, and throat (ENT) specialists and urologists. For ENT specialists, it is developing a platform and handpieces for treating snoring and rhinitis, including a handpiece for turbinate treatment utilizing Deep Subdermal Fractional RF technology. For urologists, the company markets ApexRF, a device that uses RF energy to provide temporary relief of muscle spasms and improve local blood circulation. The company supports its products with clinical evidence, having completed 105 third-party clinical studies and conducting 11 ongoing studies, along with over 110 peer-reviewed publications. It offers post-sales training and support services to physicians, including safety and instructional videos and personalized marketing assistance, to enhance procedural offerings and customer adoption.








INMD's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Inmode Ltd 966.62 370.50 93.83 49
SUBTOTAL 0.00 0.00 0.00 -

Sources: Inmode Ltd’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Inmode Ltd’s corporate clients.
For your research, we’ve provided 9 tables on Inmode Ltd corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.